NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 112 filers reported holding NEVRO CORP in Q2 2015. The put-call ratio across all filers is 2.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $350 | +10.4% | 18,219 | +46.1% | 0.00% | – |
Q2 2023 | $317 | -13.6% | 12,471 | +22.8% | 0.00% | – |
Q1 2023 | $367 | +178.0% | 10,155 | +204.5% | 0.00% | – |
Q4 2022 | $132 | -100.0% | 3,335 | -79.9% | 0.00% | -100.0% |
Q3 2022 | $773,000 | -26.9% | 16,599 | +160.8% | 0.00% | 0.0% |
Q3 2021 | $1,058,000 | -2.6% | 6,365 | -2.9% | 0.00% | 0.0% |
Q2 2021 | $1,086,000 | +583.0% | 6,554 | +472.4% | 0.00% | – |
Q1 2021 | $159,000 | +0.6% | 1,145 | -38.1% | 0.00% | – |
Q3 2019 | $158,000 | -62.5% | 1,849 | -71.6% | 0.00% | -100.0% |
Q2 2019 | $421,000 | +105.4% | 6,508 | +98.2% | 0.00% | 0.0% |
Q1 2019 | $205,000 | -24.4% | 3,284 | -53.0% | 0.00% | 0.0% |
Q4 2018 | $271,000 | +173.7% | 6,981 | +507.0% | 0.00% | -75.0% |
Q1 2018 | $99,000 | +4850.0% | 1,150 | +2775.0% | 0.00% | – |
Q4 2017 | $2,000 | -93.5% | 40 | -90.7% | 0.00% | -100.0% |
Q2 2017 | $31,000 | -93.3% | 428 | -91.3% | 0.00% | -95.0% |
Q1 2017 | $463,000 | +320.9% | 4,945 | +224.7% | 0.02% | +185.7% |
Q4 2016 | $110,000 | -37.1% | 1,523 | -51.3% | 0.01% | -50.0% |
Q1 2016 | $175,000 | -55.2% | 3,126 | -63.0% | 0.01% | -51.7% |
Q3 2015 | $391,000 | +283.3% | 8,448 | +343.7% | 0.03% | +222.2% |
Q2 2015 | $102,000 | – | 1,904 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |